AUA
  • Program
  • Register
  • Meeting Coverage
  • Guidelines
  • Industry Highlights
  • Science & Technology Hall
Topics
  • Meeting Coverage
  • Guidelines
  • Industry Highlights
  • Science & Technology Hall
Resources
  • Program
  • Register
Twitter iconFacebook iconInstagram iconYouTube iconLinkedIn icon
Mar 27, 2023

Reducing the treatment burden of testicular cancer

New treatment approaches can potentially improve long-term outcomes.


Peter Albers, MD
Peter Albers, MD

An estimated 9,190 new cases of testicular cancer will be diagnosed this year in the U.S., making it a rare but not uncommon cancer in young men, with 33 the average age of first diagnosis. About one of every 250 males will develop testicular cancer at some point in their lifetime.

“Quality of care is an important issue in view of the long-term side effects of systemic treatment, which is usually cisplatin-based chemotherapy,” said Peter Albers, MD, who will present the European Association of Urology Lecture, “Paradigm Shifts in Testicular Cancer Surgery,” on Friday, April 28, from 10:25 to 10:40 a.m.

Dr. Albers is professor of urology at Heinrich Heine University Düsseldorf and chair of the department of urology at the University Hospital in Düsseldorf, Germany. For the past four years, Dr. Albers has also chaired the Scientific Congress Office of the EAU and is double affiliated at the German Cancer Research Center, a national cancer research institute in Heidelberg.

“Testicular cancer patients usually survive to nearly 100%, but those with intense treatment suffer later from secondary malignancies and side effects of chemotherapy,” Dr. Albers said. Long-term side effects include renal insufficiency, hearing loss and heart failure, which contribute to eight to 10 years less survival compared to a healthy male population.

Dr. Albers has dedicated his scientific career to reducing the treatment burden on these young patients. In recent years, he and his team have explored less toxic surgical approaches, such as robotic retroperitoneal lymph node dissection (RPLND), the robotic resection of abdominal lymph nodes for improved staging and tested this approach in prospective trials.

During the EAU Lecture, Dr. Albers will discuss paradigm shifts in testicular cancer management to improve long-term outcomes, including:

  • Sentinel node staining and RPLND. “We are establishing a phase I/II trial that combines robotic RPLND with orchiectomy for better staging,” Dr. Albers said.
  • Using robotic RPLND to resect metastatic small seminoma and nonseminomatous germ cell tumor of the testis
  • Performing “desperate surgery” with rising markers in patients after salvage chemotherapy, with considerably favorable results
  • Performing radical surgery in patients after high-dose chemotherapy, including bone resections, to offer patients a chance for a cure

Those attending this Friday session will come away with new approaches that reduce the side effects on these young patients while improving overall outcomes.  

“Testicular cancer has high cure rates, but every change in management and guideline non-adherence needs prospective, quality-controlled data and centralized, comprehensive treatment,” Dr. Albers said.

Interesting Stories
Check out the AUA’s brand new Gold Open Access journal, <i>JU Open Plus</i>
Sponsored by AUA
Check out the AUA’s brand new Gold Open Access journal, JU Open Plus
Pacific Edge Announces Key Activities at AUA2023
Sponsored by Pacific Edge Diagnostics
Pacific Edge Announces Key Activities at AUA2023
Reshaping BPH Treatment with the iTind™ Procedure
Sponsored by Olympus
Reshaping BPH Treatment with the iTind™ Procedure
Don’t miss a thing with AUANews
Sponsored by AUA
Don’t miss a thing with AUANews
More Content
Daniel W. Lin, MD
Previews
Experts to debate best uses of PSMA-PET in prostate cancer treatment decisions
Apr 07, 2023
Bowl Winners 02
Meeting Coverage
AUA2023 Annual Meeting in pictures
Apr 07, 2023
Getty Images 1344701426
Previews
Residents Forum explores career possibilities in urology
Apr 07, 2023
Getty Images 1438547233
Previews
Supporting inclusivity and encouraging diversity in urology
Apr 07, 2023
Getty Images 530686149
Previews
Keep your career flow going
Apr 07, 2023
Jim Kovarik, MS, and Leslie Lorbacher, AGNP, MSN, RN
Previews
AUA targets the role APPs play in total patient care
Apr 07, 2023
Aua Up
Previews
Unique perspectives published for the practicing urologist
Apr 07, 2023
Getty Images 1054785410
Previews
Turn on the incubator at AUA Innovation Nexus
Apr 07, 2023
Getty Images 485896821
Guidelines
AUA is your source for Guidelines at a Glance
Mar 30, 2023
Getty Images 493216361
Previews
What to do when surgery doesn’t go as planned
Mar 27, 2023
Pawan Vasudeva, MS, MRCS, MCh
Previews
Autologous fascial sling avoids mesh sling complications
Mar 27, 2023
Kevin Turner, MD
Previews
Supporting surgeons when surgery doesn’t go as planned
Mar 09, 2023
AUA
Twitter iconFacebook iconInstagram iconYouTube iconLinkedIn icon
© 2023 Ascend Media. All rights reserved.